Abaxis, Inc. (ABAX)
-NasdaqGS 43.51 
0.71(1.61%) 4:00PM EDT|After Hours
:
43.51 0.00 (0.00%) 4:31PM EDT
| Prev Close: | 44.22 |
|---|
| Open: | 44.18 |
|---|
| Bid: | 40.00 x 300 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 45.71 |
|---|
| Beta: | 1.18 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 42.94 - 44.75 |
|---|
| 52wk Range: | 31.04 - 49.45 |
|---|
| Volume: | 168,393 |
|---|
| Avg Vol (3m): | 160,468 |
|---|
| Market Cap: | 960.70M |
|---|
| P/E (ttm): | 35.37 |
|---|
| EPS (ttm): | 1.23 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary ConferencePR Newswire(Tue, May 21)
- Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Wed, May 8)
- ABAXIS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, Apr 30)
- 3 Healthcare Stock Winners and 2 Losers After Earnings Are Digestedat Wall St. Cheat Sheet(Sun, Apr 28)
- Earnings Beat for ABAX, Sluggish OverallZacks(Fri, Apr 26)
- Oversold Conditions For Abaxis (ABAX)at TheStreet(Fri, Apr 26)
- ABAXIS CEO Discusses Q4 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Apr 25)
- Abaxis Earnings: Here’s Why Investors are Ambivalent Nowat Wall St. Cheat Sheet(Thu, Apr 25)
- Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013PR Newswire(Thu, Apr 25)
- ABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, Apr 25)
- Q4 2013 ABAXIS INC Earnings Release - After Market CloseCCBN(Thu, Apr 25)
- Abaxis downgraded by Feltl & Co.Briefing.com(Mon, Apr 22)
- Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013PR Newswire(Wed, Apr 17)
- BP Gets Booed and 2 More Analysts Downgrades To Knowat Wall St. Cheat Sheet(Fri, Apr 12)
- Abaxis slips from highs as analyst cuts ratingAP(Fri, Apr 12)
Key Statistics
| Forward P/E (1 yr): | 33.21 |
|---|
| P/S (ttm): | 5.25 |
|---|
| Ex-Dividend Date: | 13-Dec-12 |
|---|
Analysts
| Annual EPS Est
(Mar-14)
: | 1.06 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.23 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 2.93 |
|---|
Business Summary
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient-care setting to provide blood constituent measurements for clinicians worldwide.
View More